Efficient clearance of early apoptotic cells by human macrophages requires M2c polarization and MerTK induction

Journal of Immunology

Volumn 189, Issue 7, 2012, Pages 3508-3520

  Zizzo, Gaetano ^a,b   Hilliard, Brendan A ^a,b   Monestier, Marc ^a,b   Cohen, Philip L ^a,b  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TEMPLE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CD16 ANTIGEN; CD163 ANTIGEN; CD204 ANTIGEN; CD206 ANTIGEN; CD209 ANTIGEN; COLONY STIMULATING FACTOR 1; GLUCOCORTICOID; GROWTH ARREST SPECIFIC PROTEIN 6; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; LYMPHOCYTE ANTIGEN; MER TYROSINE KINASE; PROTEIN TYROSINE KINASE; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

APOPTOSIS; APOPTOTIC CELL; ARTICLE; CELL DIFFERENTIATION; CELL POLARITY; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; HUMAN CELL; M1 MACROPHAGE; M2C MACROPHAGE; MACROPHAGE; MONOCYTE; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; UPREGULATION;

APOPTOSIS; AUTOCRINE COMMUNICATION; CELL DIFFERENTIATION; CELL MOVEMENT; CELL POLARITY; CELLS, CULTURED; DENDRITIC CELLS; HUMANS; IMMUNOPHENOTYPING; MACROPHAGES; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; TRANSCRIPTIONAL ACTIVATION;

EID: 84866554651     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1200662     Document Type: Article

References (59)

1. Voll, R. E., M. Herrmann, E. A. Roth, C. Stach, J. R. Kalden, and I. Girkontaite. 1997. Immunosuppressive effects of apoptotic cells. Nature 390: 350-351.
2. Fadok, V. A., D. L. Bratton, A. Konowal, P. W. Freed, J. Y. Westcott, and P. M. Henson. 1998. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J. Clin. Invest. 101: 890-898. (Pubitemid 28096086)
3. Majai, G., Z. Sarang, K. Csomós, G. Zahuczky, and L. Fésüs. 2007. PPARgamma-dependent regulation of human macrophages in phagocytosis of apoptotic cells. Eur. J. Immunol. 37: 1343-1354. (Pubitemid 46925318)
4. Mukundan, L., J. I. Odegaard, C. R. Morel, J. E. Heredia, J. W. Mwangi, R. R. Ricardo-Gonzalez, Y. P. Goh, A. R. Eagle, S. E. Dunn, J. U. Awakuni, et al. 2009. PPAR-delta senses and orchestrates clearance of apoptotic cells to promote tolerance. Nat. Med. 15: 1266-1272.
5. A-Gonzalez, N., S. J. Bensinger, C. Hong, S. Beceiro, M. N. Bradley, N. Zelcer, J. Deniz, C. Ramirez, M. Díaz, G. Gallardo, et al. 2009. Apoptotic cells promote their own clearance and immune tolerance through activation of the nuclear receptor LXR. Immunity 31: 245-258.
6. Roszer, T., M. P. Menéndez-Gutiérrez, M. I. Lefterova, D. Alameda, V. Núñez, M. A. Lazar, T. Fischer, and M. Ricote. 2011. Autoimmune kidney disease and impaired engulfment of apoptotic cells in mice with macrophage peroxisome proliferator-activated receptor gamma or retinoid X receptor alpha deficiency. J. Immunol. 186: 621-631.
7. Scott, R. S., E. J. McMahon, S. M. Pop, E. A. Reap, R. Caricchio, P. L. Cohen, H. S. Earp, and G. K. Matsushima. 2001. Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature 411: 207-211. (Pubitemid 32455181)
8. Cohen, P. L., R. Caricchio, V. Abraham, T. D. Camenisch, J. C. Jennette, R. A. Roubey, H. S. Earp, G. Matsushima, and E. A. Reap. 2002. Delayed apoptotic cell clearance and lupus-like autoimmunity in mice lacking the c-mer membrane tyrosine kinase. J. Exp. Med. 196: 135-140. (Pubitemid 34747319)
9. Gregory, C. D., and A. Devitt. 2004. The macrophage and the apoptotic cell: an innate immune interaction viewed simplistically? Immunology 113: 1-14. (Pubitemid 39178838)
10. Krysko, D. V., K. D'Herde, and P. Vandenabeele. 2006. Clearance of apoptotic and necrotic cells and its immunological consequences. Apoptosis 11: 1709-1726. (Pubitemid 44371047)
11. Lemke, G., and T. Burstyn-Cohen. 2010. TAM receptors and the clearance of apoptotic cells. Ann. N. Y. Acad. Sci. 1209: 23-29.
12. McColl, A., S. Bournazos, S. Franz, M. Perretti, B. P. Morgan, C. Haslett, and I. Dransfield. 2009. Glucocorticoids induce protein S-dependent phagocytosis of apoptotic neutrophils by human macrophages. J. Immunol. 183: 2167-2175.
13. Todt, J. C., B. Hu, and J. L. Curtis. 2008. The scavenger receptor SR-A I/II (CD204) signals via the receptor tyrosine kinase Mertk during apoptotic cell uptake by murine macrophages. J. Leukoc. Biol. 84: 510-518.
14. Wu, Y., S. Singh, M. M. Georgescu, and R. B. Birge. 2005. A role for Mer tyrosine kinase in alphavbeta5 integrin-mediated phagocytosis of apoptotic cells. J. Cell Sci. 118: 539-553. (Pubitemid 40310121)
15. Galvan, M. D., D. B. Foreman, E. Zeng, J. C. Tan, and S. S. Bohlson. 2012. Complement component C1q regulates macrophage expression of Mer tyrosine kinase to promote clearance of apoptotic cells. J. Immunol. 188: 3716-3723.
16. Shao, W. H., A. P. Kuan, C. Wang, V. Abraham, M. A. Waldman, A. Vogelgesang, G. Wittenburg, A. Choudhury, P. Y. Tsao, T. Miwa, et al. 2010. Disrupted Mer receptor tyrosine kinase expression leads to enhanced MZ B-cell responses. J. Autoimmun. 35: 368-374.
17. Camenisch, T. D., B. H. Koller, H. S. Earp, and G. K. Matsushima. 1999. A novel receptor tyrosine kinase, Mer, inhibits TNF-alpha production and lipopolysaccharide-induced endotoxic shock. J. Immunol. 162: 3498-3503. (Pubitemid 29313601)
18. Alciato, F., P. P. Sainaghi, D. Sola, L. Castello, and G. C. Avanzi. 2010. TNFalpha, IL-6, and IL-1 expression is inhibited by GAS6 in monocytes/macrophages. J. Leukoc. Biol. 87: 869-875.
19. Tibrewal, N., Y. Wu, V. D'mello, R. Akakura, T. C. George, B. Varnum, and R. B. Birge. 2008. Autophosphorylation docking site Tyr-867 in Mer receptor tyrosine kinase allows for dissociation of multiple signaling pathways for phagocytosis of apoptotic cells and down-modulation of lipopolysaccharideinducible NF-kappaB transcriptional activation. J. Biol. Chem. 283: 3618-3627.
20. Wallet, M. A., R. R. Flores, Y. Wang, Z. Yi, C. J. Kroger, C. E. Mathews, H. S. Earp, G. Matsushima, B. Wang, and R. Tisch. 2009. MerTK regulates thymic selection of autoreactive T cells. Proc. Natl. Acad. Sci. USA 106: 4810-4815.
21. Shao, W. H., and P. L. Cohen. 2011. Disturbances of apoptotic cell clearance in systemic lupus erythematosus. Arthritis Res. Ther. 13: 202.
22. Muñoz, L. E., C. Janko, G. E. Grossmayer, B. Frey, R. E. Voll, P. Kern, J. R. Kalden, G. Schett, R. Fietkau, M. Herrmann, and U. S. Gaipl. 2009. Remnants of secondarily necrotic cells fuel inflammation in systemic lupus erythematosus. Arthritis Rheum. 60: 1733-1742.
23. Suh, C. H., B. Hilliard, S. Li, J. T. Merrill, and P. L. Cohen. 2010. TAM receptor ligands in lupus: protein S but not Gas6 levels reflect disease activity in systemic lupus erythematosus. Arthritis Res. Ther. 12: R146.
24. -/- mice. Arterioscler. Thromb. Vasc. Biol. 28: 1421-1428.
25. Liao, D., X. Wang, M. Li, P. H. Lin, Q. Yao, and C. Chen. 2009. Human protein S inhibits the uptake of AcLDL and expression of SR-A through Mer receptor tyrosine kinase in human macrophages. Blood 113: 165-174.
26. Linger, R. M., A. K. Keating, H. S. Earp, and D. K. Graham. 2008. TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer. Adv. Cancer Res. 100: 35-83. (Pubitemid 351932179)
27. Loges, S., T. Schmidt, M. Tjwa, K. van Geyte, D. Lievens, E. Lutgens, D. Vanhoutte, D. Borgel, S. Plaisance, M. Hoylaerts, et al. 2010. Malignant cells fuel tumor growth by educating infiltrating leukocytes to produce the mitogen Gas6. Blood 115: 2264-2273.
28. Oner, A. F., A. Bay, M. Kuru, A. Uner, S. Arslan, and H. Caksen. 2005. Effects of high-dose methylprednisolone therapy on coagulation factors in patients with acute immune thrombocytopenic purpura. Clin. Appl. Thromb. Hemost. 11: 489-492. (Pubitemid 41546778)
29. Ehrchen, J., L. Steinmüller, K. Barczyk, K. Tenbrock, W. Nacken, M. Eisenacher, U. Nordhues, C. Sorg, C. Sunderkötter, and J. Roth. 2007. Glucocorticoids induce differentiation of a specifically activated, anti-inflammatory subtype of human monocytes. Blood 109: 1265-1274. (Pubitemid 46220679)
30. Zahuczky, G., E. Kristóf, G. Majai, and L. Fésüs. 2011. Differentiation and glucocorticoid regulated apopto-phagocytic gene expression patterns in human macrophages. Role of Mertk in enhanced phagocytosis. PLoS ONE 6: e21349.
31. Martinez, F. O., A. Sica, A. Mantovani, and M. Locati. 2008. Macrophage activation and polarization. Front. Biosci. 13: 453-461. (Pubitemid 351599757)
32. Chen, C., Q. Li, A. L. Darrow, Y. Wang, C. K. Derian, J. Yang, L. de Garavilla, P. Andrade-Gordon, and B. P. Damiano. 2004. Mer receptor tyrosine kinase signaling participates in platelet function. Arterioscler. Thromb. Vasc. Biol. 24:1118-1123. (Pubitemid 38737840)
33. Smith, W., M. Feldmann, and M. Londei. 1998. Human macrophages induced in vitro by macrophage colony-stimulating factor are deficient in IL-12 production. Eur. J. Immunol. 28: 2498-2507. (Pubitemid 28362724)
34. Verreck, F. A., T. de Boer, D. M. Langenberg, M. A. Hoeve, M. Kramer, E. Vaisberg, R. Kastelein, A. Kolk, R. de Waal-Malefyt, and T. H. Ottenhoff. 2004. Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria. Proc. Natl. Acad. Sci. USA 101: 4560-4565. (Pubitemid 38437450)
35. Behrens, E. M., P. Gadue, S. Y. Gong, S. Garrett, P. L. Stein, and P. L. Cohen. 2003. The mer receptor tyrosine kinase: expression and function suggest a role in innate immunity. Eur. J. Immunol. 33: 2160-2167. (Pubitemid 37010033)
36. Seitz, H. M., T. D. Camenisch, G. Lemke, H. S. Earp, and G. K. Matsushima. 2007. Macrophages and dendritic cells use different Axl/Mertk/Tyro3 receptors in clearance of apoptotic cells. J. Immunol. 178: 5635-5642. (Pubitemid 46674359)
37. Gordon, S. 2003. Alternative activation of macrophages. Nat. Rev. Immunol. 3:23-35. (Pubitemid 37328697)
38. Ambarus, C. A., S. Krausz, M. van Eijk, J. Hamann, T. R. Radstake, K. A. Reedquist, P. P. Tak, and D. L. Baeten. 2012. Systematic validation of specific phenotypic markers for in vitro polarized human macrophages. J. Immunol. Methods 375: 196-206.
39. Hillyer, L. M., and B. Woodward. 2003. Interleukin-10 concentration determined by sandwich enzyme-linked immunosorbent assay is unrepresentative of bioactivity in murine blood. Am. J. Physiol. Regul. Integr. Comp. Physiol. 285:R1514-R1519. (Pubitemid 37464412)
40. Malone, D., L. M. Napolitano, T. Genuit, G. V. Bochicchio, K. Kole, and T. M. Scalea. 2001. Total cytokine immunoassay: a more accurate method of cytokine measurement? J. Trauma 50: 821-825. (Pubitemid 32499605)
41. Sulahian, T. H., P. Högger, A. E. Wahner, K. Wardwell, N. J. Goulding, C. Sorg, A. Droste, M. Stehling, P. K. Wallace, P. M. Morganelli, and P. M. Guyre. 2000. Human monocytes express CD163, which is upregulated by IL-10 and identical to p155. Cytokine 12: 1312-1321.
42. Martinez, F. O., S. Gordon, M. Locati, and A. Mantovani. 2006. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J. Immunol. 177: 7303-7311. (Pubitemid 44715100)
43. Mikołajczyk, T. P., J. E. Skrzeczyńska-Moncznik, M. A. Zarebski, E. A. Marewicz, A. M. Wiśniewska, M. Dzieba, J. W. Dobrucki, and J. R. Pryjma. 2009. Interaction of human peripheral blood monocytes with apoptotic polymorphonuclear cells. Immunology 128: 103-113.
44. Hashimoto, S., M. Yamada, K. Motoyoshi, and K. S. Akagawa. 1997. Enhancement of macrophage colony-stimulating factor-induced growth and differentiation of human monocytes by interleukin-10. Blood 89: 315-321. (Pubitemid 26428208)
45. te Velde, A. A., R. de Waal Malefijt, R. J. Huijbens, J. E. de Vries, and C. G. Figdor. 1992. IL-10 stimulates monocyte Fc gamma R surface expression and cytotoxic activity. Distinct regulation of antibody-dependent cellular cytotoxicity by IFN-gamma, IL-4, and IL-10. J. Immunol. 149: 4048-4052.
46. Williams, L., G. Jarai, A. Smith, and P. Finan. 2002. IL-10 expression profiling in human monocytes. J. Leukoc. Biol. 72: 800-809. (Pubitemid 36277852)
47. Donnelly, R. P., H. Dickensheets, and D. S. Finbloom. 1999. The interleukin-10 signal transduction pathway and regulation of gene expression in mononuclear phagocytes. J. Interferon Cytokine Res. 19: 563-573. (Pubitemid 29331308)
48. Jung, M., R. Sabat, J. Krätzschmar, H. Seidel, K. Wolk, C. Schönbein, S. Schütt, M. Friedrich, W. D. Döcke, K. Asadullah, et al. 2004. Expression profiling of IL-10-regulated genes in human monocytes and peripheral blood mononuclear cells from psoriatic patients during IL-10 therapy. Eur. J. Immunol. 34: 481-493. (Pubitemid 39255958)
49. Hallet, M. M., V. Praloran, H. Vié, M. A. Peyrat, G. Wong, J. Witek-Giannotti, J. P. Soulillou, and J. F. Moreau. 1991. Macrophage colony-stimulating factor (CSF-1) gene expression in human T-lymphocyte clones. Blood 77: 780-786.
50. Tiemessen, M. M., A. L. Jagger, H. G. Evans, M. J. van Herwijnen, S. John, and L. S. Taams. 2007. CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages. Proc. Natl. Acad. Sci. USA 104: 19446-19451.
51. Codarri, L., G. Gyülvészi, V. Tosevski, L. Hesske, A. Fontana, L. Magnenat, T. Suter, and B. Becher. 2011. RORgt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. Nat. Immunol. 12: 560-567.
52. Skrzeczyńska-Moncznik, J., M. Bzowska, S. Loseke, E. Grage-Griebenow, M. Zembala, and J. Pryjma. 2008. Peripheral blood CD14high CD16+ monocytes are main producers of IL-10. Scand. J. Immunol. 67: 152-159.
53. Belge, K. U., F. Dayyani, A. Horelt, M. Siedlar, M. Frankenberger, B. Frankenberger, T. Espevik, and L. Ziegler-Heitbrock. 2002. The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF. J. Immunol. 168: 3536-3542. (Pubitemid 34250422)
54. Phillips, J. H., C. W. Chang, and L. L. Lanier. 1991. Platelet-induced expression of Fc gamma RIII (CD16) on human monocytes. Eur. J. Immunol. 21: 895-899.
55. Xu, W., A. Roos, N. Schlagwein, A. M. Woltman, M. R. Daha, and C. van Kooten. 2006. IL-10-producing macrophages preferentially clear early apoptotic cells. Blood 107: 4930-4937. (Pubitemid 43882647)
56. Sierra-Filardi, E., M. A. Vega, P. Sánchez-Mateos, A. L. Corbí, and A. Puig-Kröger. 2010. Heme Oxygenase-1 expression in M-CSF-polarized M2 macrophages contributes to LPS-induced IL-10 release. Immunobiology 215: 788-795.
57. Caligiuri, G., M. Rudling, V. Ollivier, M. P. Jacob, J. B. Michel, G. K. Hansson, and A. Nicoletti. 2003. Interleukin-10 deficiency increases atherosclerosis, thrombosis, and low-density lipoproteins in apolipoprotein E knockout mice. Mol. Med. 9: 10-17. (Pubitemid 36667687)
58. Gleissner, C. A., I. Shaked, C. Erbel, D. Böckler, H. A. Katus, and K. Ley. 2010. CXCL4 downregulates the atheroprotective hemoglobin receptor CD163 in human macrophages. Circ. Res. 106: 203-211.
59. Solinas, G., G. Germano, A. Mantovani, and P. Allavena. 2009. Tumorassociated macrophages (TAM) as major players of the cancer-related inflammation. J. Leukoc. Biol. 86: 1065-1073.